Super Antibiotic: Teixobactin by NovoBiotic

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Take our Survey

By Doni Bloomfield

January 22, 2015 at 10:47 PM UTC

This article is for subscribers only.

This article is part of the January 26, 2015 issue of businessweek.

Innovators: Losee Ling and Tanja Schneider
Ages: 57 and 39
Vice president for R&D at startup NovoBiotic Pharmaceuticals in Cambridge, Mass.; and a researcher at the University of Bonn in Germany

 